Cover Image
市場調查報告書

GeneScience Pharmaceuticals Co., Ltd.的產品平台分析

GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293911
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
GeneScience Pharmaceuticals Co., Ltd.的產品平台分析 GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年10月14日 內容資訊: 英文 25 Pages
簡介

GeneScience Pharmaceuticals Co., Ltd.是總公司在中國的製藥企業,開發、製造、銷售兒童生長激素障礙、燙傷、腫瘤、輔助生殖技術的內分泌系統、兒童系統及相關領域的生技藥品及生物學名藥。

本報告提供GeneScience Pharmaceuticals Co., Ltd. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

GeneScience Pharmaceuticals Co., Ltd. 的基本資料

  • GeneScience Pharmaceuticals Co., Ltd. 概要
  • 主要資訊
  • 企業資料

GeneScience Pharmaceuticals Co., Ltd. :R&D概要

  • 主要的治療範圍

GeneScience Pharmaceuticals Co., Ltd. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

GeneScience Pharmaceuticals Co., Ltd. :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
  • 開發階段不明的開發中產品
    • 開發階段不明的產品/聯合治療模式

GeneScience Pharmaceuticals Co., Ltd.:藥物簡介

  • Gensci-006
  • Gensci-007
  • Gensci-008
  • Gensci-003
  • Gensci-028

GeneScience Pharmaceuticals Co., Ltd. :開發平台分析

GeneScience Pharmaceuticals Co., Ltd. :各分子類型

GeneScience Pharmaceuticals Co., Ltd. :現在暫停中的計劃

GeneScience Pharmaceuticals Co., Ltd. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07656CDB

Summary

Global Markets Direct's, 'GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the GeneScience Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of GeneScience Pharmaceuticals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of GeneScience Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of GeneScience Pharmaceuticals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the GeneScience Pharmaceuticals Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate GeneScience Pharmaceuticals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of GeneScience Pharmaceuticals Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the GeneScience Pharmaceuticals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of GeneScience Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of GeneScience Pharmaceuticals Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of GeneScience Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • GeneScience Pharmaceuticals Co., Ltd. Snapshot
    • GeneScience Pharmaceuticals Co., Ltd. Overview
    • Key Information
    • Key Facts
  • GeneScience Pharmaceuticals Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products Glance
    • GeneScience Pharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • GeneScience Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • GeneScience Pharmaceuticals Co., Ltd. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • GeneScience Pharmaceuticals Co., Ltd. - Drug Profiles
    • Pegylated somatropin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gensci-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gensci-007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gensci-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gensci-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gensci-028
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Analysis
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Target
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action
  • GeneScience Pharmaceuticals Co., Ltd. - Dormant Projects
  • GeneScience Pharmaceuticals Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • GeneScience Pharmaceuticals Co., Ltd., Key Information
  • GeneScience Pharmaceuticals Co., Ltd., Key Facts
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Phase II, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Preclinical, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Unknown, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Target, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2015

List of Figures

  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top